SELLAS Life Sciences
27 hedge funds and large institutions have $9.59M invested in SELLAS Life Sciences in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 8 closing their positions.
281% more call options, than puts
Call options by funds: $2.31M | Put options by funds: $607K
0.8% less ownership
Funds ownership: 11.72% → 10.91% (-0.8%)
10% less funds holding
Funds holding: 30 → 27 (-3)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
44% less capital invested
Capital invested by funds: $17.1M → $9.59M (-$7.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$715K |
| 2 |
VF
Virtu Financial
New York
|
+$105K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$79K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$52.6K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.08M |
| 2 |
Morgan Stanley
New York
|
-$460K |
| 3 |
Jane Street
New York
|
-$154K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$147K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$134K |
SLS Hedge Fund Activity: Q4 2021 in Review
27 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q4 2021, worth a combined $9.59M — down 44% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SLS and 5 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Ameriprise, opening a new position worth an estimated $715K. The largest seller was Bank of Montreal, exiting entirely with an estimated $1.08M sold.
- 27 institutional investors held SELLAS Life Sciences (SLS) as of Q4 2021, down from 30 in Q3 2021.
- Funds reported $9.59M of SELLAS Life Sciences stock for Q4 2021, down 44% quarter-over-quarter.
- 5 funds opened new SELLAS Life Sciences positions in Q4 2021 and 8 closed out, a net change of -3 holders.
- The largest SELLAS Life Sciences buyer in Q4 2021 was Ameriprise, an estimated $715K added.
- The largest SELLAS Life Sciences seller in Q4 2021 was Bank of Montreal, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2021.